MoonLake Immunotherapeuti... (MLTX)
NASDAQ: MLTX
· Real-Time Price · USD
54.42
-0.46 (-0.84%)
At close: Aug 15, 2025, 3:59 PM
54.39
-0.06%
After-hours: Aug 15, 2025, 04:20 PM EDT
MoonLake Immunotherapeutics Ratios and Metrics
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
PE Ratio | -13.52 | -15.34 | -18.72 | -22.4 | -27.08 | -55.66 | -121.63 | -80.91 | -54.98 | -17.1 | -52.69 | -4.86 | -2.65 | -6.45 | -16.47 | -14.61 | -2.92 | -494.85 |
PEG Ratio | -0.35 | 1.23 | -0.66 | -0.51 | -0.35 | -0.67 | 3.65 | 3.72 | 2.13 | -0.03 | 0.60 | 0.26 | -0.19 | -0.03 | 1.40 | 0.18 | -0.00 | 47.84 |
PS Ratio | n/a | n/a | 33.53K | n/a | n/a | n/a | 183.31K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
PB Ratio | 8.44 | 6.06 | 7.64 | 6.50 | 5.05 | 5.61 | 7.30 | 7.18 | 4.55 | 19.89 | 8.34 | 5.18 | 2.91 | 16.80 | -12.57 | 3.34 | 3.40 | 1.34 |
P/FCF Ratio | -54.78 | -64.72 | -70.2 | -124.82 | -94.23 | -200.8 | -286.5 | -329.76 | -183.38 | -92.59 | -35.17 | -30.64 | -8.9 | -28.86 | -374.98 | -180.97 | 62.24K | -1.4K |
P/OCF Ratio | -54.78 | -64.78 | -70.46 | -125.47 | -94.23 | -203.65 | -293.11 | -329.76 | -183.38 | -92.59 | -35.17 | -30.64 | -8.9 | -28.89 | -404.52 | -182.01 | 62.24K | -1.4K |
OCF/S Ratio | n/a | n/a | -475.93 | n/a | n/a | n/a | -625.41 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Debt / Equity Ratio | 0.21 | 0.19 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.00 | 0.00 | 0.01 | 0.01 | n/a | n/a | 0.62 | -1.29 | n/a | n/a | n/a |
Quick Ratio | 16.65 | 21.11 | 21.11 | 25.51 | 43.71 | 62.13 | 51.59 | 48.51 | 70.97 | 9.14 | 9.98 | 14.71 | 25.51 | 0.57 | 0.46 | 0.59 | 14.79 | 24.33 |
Current Ratio | 16.65 | 21.11 | 21.11 | 25.51 | 43.71 | 62.13 | 51.59 | 48.51 | 70.97 | 9.14 | 9.98 | 14.71 | 25.51 | 0.57 | 0.46 | 0.59 | 14.79 | 24.33 |
Asset Turnover | n/a | n/a | 0.00 | n/a | n/a | n/a | 0.00 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Interest Coverage | -29.8 | 2.64K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Return on Equity | -0.16 | -0.1 | -0.1 | -0.07 | -0.05 | -0.03 | -0.02 | -0.02 | -0.02 | -0.29 | -0.04 | -0.27 | -0.27 | -0.65 | 0.19 | -0.06 | -0.29 | n/a |
Return on Assets | -0.12 | -0.08 | -0.1 | -0.07 | -0.04 | -0.02 | -0.01 | -0.02 | -0.02 | -0.18 | -0.03 | -0.17 | -0.18 | -0.07 | -0.23 | -0.05 | -0.28 | n/a |
Return on Invested Capital | -0.14 | -0.1 | -0.11 | -0.09 | -0.06 | -0.04 | -0.03 | -0.03 | -0.03 | -0.22 | -0.24 | -0.18 | -0.19 | -0.37 | -0.62 | -0.05 | -0.28 | n/a |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | n/a | n/a | 0.50 | n/a | n/a | n/a | 0.83 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Net Profit Margin | n/a | n/a | -447.76 | n/a | n/a | n/a | -376.79 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Profit Margin | n/a | n/a | -455.13 | n/a | n/a | n/a | -397.36 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Profit Margin | n/a | n/a | -486.8 | n/a | n/a | n/a | -761.42 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | n/a | n/a | -442.35 | n/a | n/a | n/a | -761.25 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |